Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Antioxidants Line Goes Back To Raschig
April 7, 2008
| A version of this story appeared in
Volume 86, Issue 14
German specialty chemical firm Raschig has repurchased a phenolic antioxidant business it sold to Evonik Industries predecessor Degussa in 2002. In May 2007, Evonik sold the antioxidant business to Arques Industries, a German investment firm, for what Arques said was a token price. Arques now has sold the business to Raschig for $16.5 million. The business, called Oxiris Chemicals, employs 50 people at a plant in Sant Celoni, Spain, and has annual sales of about $42 million. Raschig says the purchase, the biggest in its history, will improve profits.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X